Navigation Links
Concord Medical Acquires Ownership Interest in MD Anderson Cancer Center Proton Therapy Center
Date:12/13/2012

BEIJING, Dec.13, 2012 /PRNewswire-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical," or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced the signing of a definitive agreement under which it will acquire 19.98% of indirect ownership of The University of Texas MD Anderson Cancer Center Proton Therapy Center (MD Anderson Proton Therapy Center), achieved through acquiring a minority interest in the general partner and facility manager.  The purchase price of the all-cash transaction was not disclosed.  Concord Medical purchased the interest from the existing owners of the general partner, and the transaction does not affect MD Anderson's ownership in the Proton Therapy Center.

After the acquisition closes, Concord Medical will become the second largest owner of the MD Anderson Proton Therapy Center, behind MD Anderson Cancer Center.  Concord Medical will join both the Board of Directors of the PTC-Houston Management, LP, the general partner of the center, and the center's Advisory Committee.

"We're very excited to partner with MD Anderson Proton Therapy Center, one of the leading proton treatment centers in the world," says Dr. Jianyu Yang, CCM Chairman and CEO. "Proton treatment has become a widely accepted method of radiation therapy.  Concord Medical plans to build and operate two proton centers in China. This transaction will enable us to gain valuable experience and knowledge of the operations of a proton therapy center from the world leader in proton therapy cancer care."

"MD Anderson welcomes Concord Medical to the partnership," says Dan Fontaine, senior vice president of business affairs for MD Anderson. "The clinical expertise and quality programs provided by our faculty and staff is why our Proton Therapy Center is the leader in the field."

"The MD Anderson Proton Therapy Center welcomes Concord Medical.  It brings more than 15 years of experience into the partnership," commented John Styles, Jr., CEO of the center.  "We look forward to working closely with the CCM team".

Both the general partner's and Concord Medical's Boards of Directors have approved the agreement, and the transaction is expected to close by the end of 2012, subject to customary closing conditions and approvals.

MD Anderson Proton Therapy Center is an affiliate of MD Anderson. Opened in 2006, it was the fourth proton treatment center in the U.S. Since it's opening, the center has treated more than 4,000 patients, accounting for 15% of the total number of patients who received proton treatment nationally.  For nine of the past 11 years, including 2007-2012, MD Anderson has been ranked No. 1 in cancer care in the U.S. News & World Report's "Best Hospitals" survey. 

About Concord Medical

Concord Medical Services Holdings Limited operates the largest network of radiotherapy and diagnostic imaging centers in China, measured by revenues and the number of centers in operation.

As of September 30, 2012, the Company operated a network of 134 centers with 75 hospital partners that spanned 53 cities and 24 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, Concord Medical provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.concordmedical.com.

Investor and Media Contacts:

Concord Medical Services
Mr. Adam J. Sun
adam.sun@concordmedical.com
(+86) 10 5957-5266

Ms. Gloria Huang
gloria.huang@concordmedical.com
(+86) 10 5903-6688 (ext. 639)

Solebury Communications

In China:
Ms. Vickie Zhao
CCM@soleburyir.com
(+86) 10 6563-0288 (ext.801)

In the United States:
Mr. Richard Zubek
rzubek@soleburyir.com
(+1) 203-428-3230 


'/>"/>
SOURCE Concord Medical Services Holdings Limited
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Concord Medical to Hold Annual General Meeting on December 22, 2012
2. Concord Medical Reports Third Quarter 2012 Financial Results
3. Concord Medical Announces Change to Third Quarter Financial Results Date to November 20, 2012
4. Concord Medical to Report Third Quarter 2012 Financial Results on November 21, 2012
5. Concord Medical Responds to Unusual Market Activity in its Stock
6. Concord Medical Reports Second Quarter 2012 Financial Results
7. Concord Medical to Report Second Quarter 2012 Financial Results on August 20, 2012
8. Concordia Study Indicates Obesity is Becoming the Nations Top Health Issue
9. Concord Medicals Changan Hospital and Fox Chase Cancer Center Sign Strategic Alliance Agreement
10. CyberKnife System and the da Vinci Surgical System in Concord Medical Centers Achieve Over RMB 10 Million in Medical Revenue Since Opening in February
11. Concord Medical Announces its Successful Closing of the Acquisition of 52% Ownership in Changan Hospital and Provides Guidance for Financial Results of the Second Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... VEGAS , June 26, 2016 ... to value-based care operating models within the health care ... enable greater financial efficiency , Deloitte offers a ... the key business issues impacting efficient cost optimization: labor ... , These services facilitate better outcomes and better ...
(Date:6/24/2016)... 2016  Collagen Matrix, Inc., ("Collagen Matrix") the ... of collagen and mineral based medical devices for ... Bill Messer has joined the company as ... the growing portfolio of oral surgery, neurosurgery, orthopaedic ... joins the Collagen Matrix executive team as an ...
Breaking Medicine Technology:
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
(Date:6/24/2016)... , ... June 24, 2016 , ... National recruitment firm ... life sciences executive with extensive sequencing and genomics experience, as Vice President of North ... Ms. Hill will be responsible for leading the sales team in the commercialization of ...
Breaking Medicine News(10 mins):